Belfast Health and Social Care Trust has licensed its rapid molecular diagnostic for Group B streptococcus to HiberGene Diagnostics Ltd. The Group B streptococcus assay is 100% sensitive and 93% specific when compared to direct culture.
Read more ...
Belfast Trust licenses patent to HiberGene Diagnostics HSC Innovations is pleased to announce that Belfast Health and Social Care Trust has licensed its novel rapid meningitis diagnostic test to HiberGene Diagnostics Ltd, a start-up client company of NovaUCD, the Innovation and Technology Transfer Centre, Dublin, Ireland. Novel Rapid Meningitis Diagnostic Test Moves Closer To
Read more ...